Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. Boston Scientific is committed to changing this statistic by supporting the Colorectal Cancer Alliance.
In support of Colorectal Cancer Awareness Month, Boston Scientific is donating a percentage of sales made in March to the Colorectal Cancer Alliance's Blue Hope Program to support colon cancer preventation and awareness.
Boston Scientific will donate 1% of sales for products used to diagnose and treat conditions caused by colorectal cancer during the month of March to the Colorectal Cancer Alliance's Blue Hope Program, with a maximum donation amount of $75,000. This program applies to colonic stents, snares, clips, biopsy forceps and Orise™ Gel submucosal lifting agent sold from March 1-31, 2020.